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Although tetanus is a rare disease in the developed countries now, it remains a significant cause of death world-wide and is associated with a high rate of mortality. Components of severe tetanus management are supportive care with sedation, airway protection and controlled ventilation. [1] Dexmedetomidine is a high selective α-2-receptor agonist. It has combined analgesic and anti-sympathetic effect without respiratory system depression. There have been several studies describing its successful use in mechanically ventilated patients for short-(24 h) and long-term (up to 7 days) use in the intensive care unit (ICU). [2] Dexmedetomidine has been also used in the treatment of tetanus in six patients for 7 days. [3] We present a case of generalised tetanus complicated by uncontrolled sympathetic over activity (SOA) managed with dexmedetomidine infusion.
A 53-year-old male patient presented with complaints of dyspnoea, upper lip twitching, difficulty in swallowing and a local abscess around his right foot. He had a medical history of penetrating wound in his right foot 11 days before. Antibiotics and human tetanus immunoglobulin were administered and the wound was surgically debrided. Because of respiratory failure with SOA, he was intubated and mechanically ventilated. SOA persisted despite midazolam and magnesium sulphate infusion. Dexmedetomidine infusion was started on day 5 and SOA could be controlled successfully. On day 10, severe bronchopneumonia developed and the patient died on day 12.
The management of tetanus requires the prevention of tetanospasmin absorption, treatment of symptoms, stabilisation of autonomic instability, antibiotic therapy and control of the airway with assisted ventilation if indicated. Basal SOA is characterised by resting tachycardia and depression of bowel motility and bladder function, while severe SOA presents with fluctuating tachycardia, labile hypertension and sweating with and without stimulation. [4] Different methods to control SOA have been provided, including magnesium sulphate infusions, dantrolene infusions, intrathecal administration of baclofen, benzodiazepine, clonidine and dexmedetomidine. [5] Girgin et al. [3] reported use of dexmedetomidine in the management of tetanus for 7 days in six patients without any side-effects. According to the same author, its administration did not fully control the muscle spasm, but decreased their frequency and severity and reduced the use of sedative drugs to control muscle spasms and cardiovascular instability. In this case, we started dexmedetomidine infusion on the 5 th day in the ICU, because midazolam and magnesium sulphate infusions did not efficiently control SOA. We observed that tachycardia (heart rate >110 beats/ min) and hypertension (mean arterial blood pressure >100 mmHg) decreased to acceptable normal levels and need for sedative drugs was reduced after starting dexmedetomidine infusion. However, we were not able to fully avoid their use. We used dexmedetomidine for 4 days. Although hypotension and bradycardia are the most significant side-effects, we did not observe any of these and could control SOA during the first 3 days of the infusion. However, hypotension and bradycardia were observed on the 4 th day of the infusion and hence we cut it off. The patient died because of nosocomial pneumonia despite multidrug antibiotherapy. Thus, dexemedetomidine can be a good alternative drug for resistant SOA during tetanus management.
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Acute sialadenitis of parotid gland: Anaesthesia mumps
Sir, Acute swelling of the parotid gland, a very rare complication observed after general anaesthesia during the peri-operative period was first reported by Attas et al. [1] later named as ' Anaesthesia mumps' [2] and which regresses without any medications. [1] [2] [3] [4] We report acute sialadenitis of the right parotid gland after surgery for spondylolisthesis in prone position.
A 54-year-old obese (body mass index = 30.8 kg/m 2 ) lady diagnosed with spondylolisthesis on magnetic resonance imaging was advised spinal fusion surgery of L2-L3, L4-L5 under general anaesthesia. She had hypertension and hypothyroidism both of which were under control. Her pre-operative haemoglobin was 10 g%. Patient was premedicated with Alprazolam 0.5 mg orally on the day before surgery. In the operating room, intravenous access with 18G cannula was secured and standard monitoring included electrocardiogram, non-invasive blood pressure, end tidal concentration of carbon-dioxide and pulse oximetry. Induction was achieved with thiopentone sodium 4-5 mg/kg of 2.5% solution, titrated to loss of eye lash reflex. Analgesia was provided with fentanyl 2 mickg −1 . Endotracheal intubation was facilitated by using vecuronium bromide as muscle relaxant (0.1 mg / kg) and anaesthesia was maintained with sevoflurane (1%) with N 2 O:O 2 (66:33). Endotracheal tube was fixed to the right without any pressure on the cheeks and was plastered without any pressure. Mechanical ventilation was started with volume controlled ventilation using, tidal volume of 8 ml/ kg and respiratory rate of 12/min. Patient was positioned in prone position with adequate padding of eyes and also supporting with the bolsters under the chest and hips. The head was in neutral position (parallel to the heart) and was not changed intra-operatively. Head rest was made of foam with a central hemicircle opening and a small passage for the endotracheal tube to the right side. Intra-operatively, muscle relaxation was provided using neuromuscular monitoring and depth of anaesthesia was monitored by Bispectral index, intravenous fluids using crystalloids and colloids given and urine output maintained at 0.5-1 ml/kg/h. Intra-operative mean arterial blood pressure was maintained at 70-80 mmHg. Patient did not require inotropes or vasopressors. Total duration of surgery was 5 h and the blood loss was 600 ml. In view of post-operative bleeding and for proper wound healing, blood was transfused. After surgery patient was turned supine and extubated after reversal of residual neuromuscular blockade with injection neostigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg. In the post-operative period after 6 h a bilateral swelling of the parotid gland in the pre-auricular and post-auricular region was noted extending to the angle of mandible. Swelling was more on the right side of the face lifting the auricle [ Figure 1 ] with no signs of inflammation; skin over the swelling was soft without any local rise of temperature and was painless. The patient was reassured, administered 1 g of intravenous methyl prednisolone. Suspecting renal abnormality, renal function tests and electrolytes were
